Dossier
rss
preclinical
Inhibition of Abnormal Elevated α‐Synuclein Ameliorates Dopaminergic Neuron Degeneration in Parkinson’s Disease Mouse Model
Key claim: Inhibiting abnormally elevated α-synuclein ameliorates dopaminergic neuron degeneration in a Parkinson’s disease mouse model.
Abstract
Aging Cell, Volume 25, Issue 10, October 2026.
Why this matters
Inhibiting abnormally elevated α-synuclein ameliorates dopaminergic neuron degeneration in a Parkinson’s disease mouse model.